centralPAdude said...
I expect that a small fraction of surgeries release cancer cells into the body following surgery, which results in BCR. It just makes too much sense.
It is not unusual for there to be circulating tumor cells (CTC) when one has prostate cancer. Fortunately, these cells have an
extraordinarily difficult time establishing themselves outside the prostate in other organs/tissue as metastases. Over time (usually years---and
many years at that), in some men the prostate can produce CTC that do have the ability to seed and grow, forming mets. AFAIK, mechanical release (e.g. via surgery or biopsy) is not generally accepted as causing PC to metastasize (one theory is that these CTC have to circulate back through the prostate--perhaps many times--to gain met potential). Even then, considering the numbers of CTC found in these patients, a malignant cell that does manage to seed somewhere is a rare event.
Evidence of this comes from clonal studies looking at the exact lesion of origin of the mets in a given patient. It seems that it is often the case that
all of one's metastases can be traced back to a
single lesion in the prostate, even though PC is a heterogenous disease with men often presenting with multiple lesions and with multiple Gleason scores. If it were so easy for cells to gain met potential, you would expect that one's mets would come from several or all of one's lesions within the prostate.
In fact, perhaps only 50% of men who do encounter BCR go on to clinical recurrence (obviously, since you don't know whether you will or you wont, most men opt for salvage treatment when BCR presents, unless they are at an advanced age: if I remember, it can take 3-8 (avg. 5) years to go from BCR to clinical recurrence, if, that is, you are going to.
Djin
Post Edited (DjinTonic) : 9/15/2022 11:02:00 AM (GMT-7)